|
Listen to this text  |
Neocis, which has developed the Yomi robotic to help in dental implant surgical procedures, has introduced in $20 million in funding. The Miami-based firm plans to make use of the funding for enterprise initiatives together with product improvement, gross sales enablement, and medical training.
“The latest investment is a testament to our growth as a company and how far dental robotics has come since the first Yomi systems were installed,” said Alon Mozes, Neocis’ co-founder and CEO, in a launch.
“This funding positions us for continued success in the market and will help us drive meaningful innovation in implant dentistry,” he stated.
Inside the Yomi surgical robotic
The U.S. Food and Drug Administration (FDA) has cleared Yomi for robot-assisted dental surgical procedure. The system has a complete of 16 FDA 510(ok) clearances. To date, greater than 40,000 implants have been positioned with Yomi, and a brand new element implant is positioned each six minutes, in accordance with Neocis.
The firm defined that Yomi assists clinicians throughout all phases of implant placement utilizing streamlined digital planning and haptic steerage of surgical instrumentation. It may also be used for performing guided bone discount, often known as alveoplasty, of the mandible and maxilla, a typical dental process sometimes carried out following a tooth extraction.
The robotic augments the surgeon’s experience. It isn’t autonomous, and the doctor retains management of instrumentation always. Yomi guides the doctor utilizing bodily suggestions, on-screen alerts, and audio cues, stated Neocis.
The system additionally assists within the planning phases of dental implant surgical procedures. The firm gives YomiPlan, a software program suite that may assist medical groups create exact therapy plans and execute instances effectively.
“Robotics and AI are changing the face of dentistry, enabling innovations that increase doctor efficiency and help them improve the quality of life for their patients,” stated Mohamed “Sid” Siddeek, company vp and head of NVentures. “Neocis is transforming dental implant procedures, demonstrating the benefits of robotics and AI in healthcare.”
Investors infuse Neocis with funding
This funding spherical’s individuals included Mirae Asset Capital/Mirae Asset Venture Investment, and NVentures, NVIDIA’s enterprise capital unit. It additionally included enterprise capital companies affiliated with the Mirae Asset Financial Group, which invests in growth-stage healthcare and know-how companies.
“Neocis is bringing needed innovation to dentistry, and we couldn’t be more excited to support them in that mission,” stated Soojung Kim, funding supervisor at Mirae Asset Capital, in a launch. “We look forward to working alongside the Neocis team to help them excel in a rapidly growing market and get Yomi in the hands of more providers.”
“We’re tremendously grateful to have the backing of our newest investors, including NVentures and Mirae Asset Financial Group, as well as our existing partners,” stated Mozes.